Washington State Court Issues Order Requiring Acucela To Hold Special Shareholders Meeting

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that on March 13, 2015 (Pacific Daylight Time), the Washington state superior court presiding over a previously-disclosed lawsuit filed by SBI Holdings, Inc. and certain of its affiliates (collectively, “SBI”), and Ryo Kubota, MD, PhD, Acucela’s founder and Chairman, issued an order requiring the Company to hold a special shareholders meeting in response to SBI’s previously-disclosed January 28, 2015 demand letter no later than May 1, 2015 (Pacific Daylight Time), and to give notice of such a meeting as soon as practicable.

Help employers find you! Check out all the jobs and post your resume.